688185.SS SHH
CanSino Biologics Inc.
1W: +28.7%
1M: +36.1%
3M: +96.0%
YTD: +56.9%
1Y: +22.6%
3Y: +27.1%
5Y: -84.7%
¥102.64 ($15.30)
+17.11 (+20.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$0
+100.0% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
$0
+100.0% ▲
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$1.6B
-217.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.9B | -$1.2B | -$2.0B | -$379M | $28M |
| Depreciation & Amort. | $89M | $196M | $269M | $211M | $0 |
| Stock-Based Comp. | $10M | $10M | $10M | $3M | $0 |
| Change in Working Capital | $84M | -$1.5B | -$157M | -$116M | $0 |
| Other Non-Cash Items | -$32M | $766M | $941M | $111M | -$28M |
| Operating Cash Flow | $2.0B | -$1.9B | -$916M | -$169M | $0 |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.2B | -$1.1B | -$610M | -$357M | $0 |
| Acquisitions (Net) | -$65M | -$3M | -$25K | $0 | $0 |
| Investment Purchases | -$8.5B | -$12.4B | -$8.1B | -$12.9B | $0 |
| Investment Sales | $7.1B | $12.2B | $8.3B | $13.3B | $0 |
| Other Investing | $94M | $36M | -$40M | -$46M | $0 |
| Investing Cash Flow | -$2.5B | -$1.2B | -$442M | $4M | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $990M | $1.3B | $69M | -$260M | $0 |
| Stock Repurchased | $0 | -$150M | $0 | -$7M | $0 |
| Dividends Paid | -$14M | -$194M | -$4M | -$64M | $0 |
| Other Financing | $584M | -$70M | -$90M | -$10M | $0 |
| Financing Cash Flow | $1.6B | $855M | -$8M | -$334M | $0 |
| Net Change in Cash | $1.0B | -$2.1B | -$1.3B | -$490M | -$1.6B |
| Cash End of Period | $5.5B | $3.4B | $2.0B | $1.6B | $0 |
| Free Cash Flow | $811M | -$3.0B | -$1.5B | -$626M | $0 |